WCM Investment Management LLC Cuts Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

WCM Investment Management LLC cut its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 69.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 243,791 shares of the company's stock after selling 564,260 shares during the period. WCM Investment Management LLC owned 0.50% of Azenta worth $12,038,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. BNP Paribas Financial Markets boosted its holdings in shares of Azenta by 43.5% in the 1st quarter. BNP Paribas Financial Markets now owns 13,672 shares of the company's stock worth $824,000 after purchasing an additional 4,144 shares during the period. Janney Montgomery Scott LLC raised its position in Azenta by 9.3% during the first quarter. Janney Montgomery Scott LLC now owns 5,167 shares of the company's stock worth $311,000 after acquiring an additional 438 shares during the period. GSA Capital Partners LLP purchased a new stake in Azenta during the 1st quarter valued at about $465,000. Envestnet Portfolio Solutions Inc. increased its holdings in shares of Azenta by 1.7% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 13,488 shares of the company's stock worth $813,000 after buying an additional 229 shares during the last quarter. Finally, Susquehanna Fundamental Investments LLC purchased a new stake in shares of Azenta during the 1st quarter valued at approximately $615,000. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Azenta

In other news, CFO Herman Cueto sold 1,595 shares of the firm's stock in a transaction that occurred on Thursday, October 17th. The shares were sold at an average price of $43.68, for a total transaction of $69,669.60. Following the completion of the transaction, the chief financial officer now directly owns 24,604 shares of the company's stock, valued at $1,074,702.72. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.77% of the company's stock.

Wall Street Analysts Forecast Growth

AZTA has been the topic of a number of recent analyst reports. Evercore ISI dropped their target price on shares of Azenta from $53.00 to $50.00 and set an "in-line" rating on the stock in a research report on Tuesday, October 1st. Needham & Company LLC reissued a "buy" rating and set a $69.00 price target on shares of Azenta in a research report on Wednesday, August 7th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Azenta presently has an average rating of "Hold" and a consensus price target of $66.40.

Azenta Stock Performance

Shares of AZTA stock traded up $0.15 during mid-day trading on Tuesday, reaching $45.99. The company's stock had a trading volume of 877,171 shares, compared to its average volume of 495,830. Azenta, Inc. has a 1-year low of $40.24 and a 1-year high of $69.16. The company has a market cap of $2.25 billion, a P/E ratio of -16.31 and a beta of 1.48. The firm's 50-day moving average is $45.87 and its two-hundred day moving average is $50.68.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.